Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 459,000 | N/A | N/A | N/A | 387,000 |
| Depreciation Amortization | 128,000 | N/A | N/A | N/A | 0 |
| Other Working Capital | -173,000 | N/A | N/A | N/A | 114,000 |
| Other Operating Activity | 99,000 | 0 | 0 | 0 | 158,000 |
| Operating Cash Flow | $513,000 | $N/A | $N/A | $N/A | $659,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -491,000 | N/A | N/A | N/A | -265,000 |
| Net Acquisitions | 0 | N/A | N/A | N/A | -54,000 |
| Investing Cash Flow | $-491,000 | $N/A | $N/A | $N/A | $-319,000 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -108,000 | N/A | N/A | N/A | -87,000 |
| Other Financing Activity | -4,000 | 0 | 0 | 0 | -183,000 |
| Financing Cash Flow | $-112,000 | $N/A | $N/A | $N/A | $-270,000 |
| Exchange Rate Effect | -3,000 | N/A | N/A | N/A | 2,000 |
| Beginning Cash Position | 365,000 | N/A | N/A | N/A | 313,000 |
| End Cash Position | 272,000 | N/A | N/A | N/A | 385,000 |
| Net Cash Flow | $-93,000 | $N/A | $N/A | $N/A | $72,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 513,000 | N/A | N/A | N/A | 659,000 |
| Free Cash Flow | 513,000 | 0 | 0 | 0 | 659,000 |